Case report: Somatic mutations in microtubule dynamics-associated genes in patients with WNT-medulloblastoma tumors

Area of Science:

• Neuro-oncology
• Genetics
• Pediatric Oncology

Background:

• Medulloblastoma (MB) is the most common malignant pediatric brain tumor, originating from early brain development precursor cells.
• WNT-subtype MB generally has a high remission rate (~90% survival), but rare cases exhibit increased metastatic activity, reducing favorable outcomes.
• Pediatric brain tumors occur at approximately 5 cases per 1 million children annually, with MB being the most frequent.

Observation:

• Two cases of MB with desmoplastic/nodular (DP) and classic histological patterns were genetically classified as WNT-MB.
• These cases, though rare, presented with increased metastatic activity, challenging the typical WNT-MB prognosis.
• Somatic protein truncating mutations were identified in microtubule-associated genes, specifically ARID2, TUBB4A, and ANK3.

Findings:

• The study identified putative causal somatic mutations in ARID2, TUBB4A, and ANK3 in WNT-MB cases.
• These mutations in microtubule-associated genes represent novel genetic drivers in this specific MB subtype.
• The findings link specific genetic alterations to aggressive WNT-MB phenotypes.

Implications:

• Identifying novel mutations in WNT-MB may lead to targeted therapies for aggressive or metastatic forms.
• Understanding these genetic underpinnings can improve diagnostic accuracy and prognostic predictions for pediatric brain tumors.
• Further research into these microtubule-associated genes could uncover new therapeutic strategies for medulloblastoma.